These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24639871)

  • 1. Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.
    Lahera T; Calvo A; Torres G; Rengifo CE; Quintero S; Arango Mdel C; Danta D; Vázquez JM; Escobar X; Carr A
    J Oncol; 2014; 2014():482301. PubMed ID: 24639871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.
    Blanco R; Rengifo CE; Cedeño M; Frómeta M; Rengifo E; Carr A
    Patholog Res Int; 2012; 2012():235418. PubMed ID: 22482082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.
    Blanco R; Blanco D; Quintana Y; Escobar X; Rengifo CE; Osorio M; Gutiérrez Z; Lamadrid J; Cedeño M; Frómeta M; Carr A; Rengifo E
    Patholog Res Int; 2013; 2013():920972. PubMed ID: 24381785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.
    Torbidoni AV; Scursoni A; Camarero S; Segatori V; Gabri M; Alonso D; Chantada G; de Dávila MT
    Acta Ophthalmol; 2015 Jun; 93(4):e294-300. PubMed ID: 25403557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System.
    Blanco R; Rengifo E; Cedeño M; Rengifo CE; Alonso DF; Carr A
    ISRN Gastroenterol; 2011; 2011():645641. PubMed ID: 21991524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin.
    Blanco R; Quintana Y; Blanco D; Cedeño M; Rengifo CE; Frómeta M; Ríos M; Rengifo E; Carr A
    J Biomark; 2013; 2013():602417. PubMed ID: 26317019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas.
    Pilco-Janeta D; De la Cruz Puebla M; Soriano J; Osorio M; Caballero I; Pérez AC; Savon L; Cremades N; Blanco R; Carr A
    BMC Cancer; 2019 Jun; 19(1):556. PubMed ID: 31182063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.
    Blanco R; Rengifo E; Rengifo CE; Cedeño M; Frómeta M; Carr A
    ISRN Dermatol; 2011; 2011():848909. PubMed ID: 22363862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences.
    Blanco R; Domínguez E; Morales O; Blanco D; Martínez D; Rengifo CE; Viada C; Cedeño M; Rengifo E; Carr A
    Patholog Res Int; 2015; 2015():132326. PubMed ID: 26634172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.
    Casadesús AV; Fernández-Marrero Y; Clavell M; Gómez JA; Hernández T; Moreno E; López-Requena A
    Glycoconj J; 2013 Oct; 30(7):687-99. PubMed ID: 23547010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and molecular interactions of a unique antitumor antibody specific for N-glycolyl GM3.
    Krengel U; Olsson LL; Martínez C; Talavera A; Rojas G; Mier E; Angström J; Moreno E
    J Biol Chem; 2004 Feb; 279(7):5597-603. PubMed ID: 14627696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the
    Bousquet PA; Manna D; Sandvik JA; Arntzen MØ; Moreno E; Sandvig K; Krengel U
    Front Immunol; 2022; 13():994790. PubMed ID: 36439103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key role of a structural water molecule for the specificity of 14F7-An antitumor antibody targeting the NeuGc GM3 ganglioside.
    Bjerregaard-Andersen K; Abraha F; Johannesen H; Oscarson S; Moreno E; Krengel U
    Glycobiology; 2021 Dec; 31(11):1500-1509. PubMed ID: 34735569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors.
    Carr A; Mullet A; Mazorra Z; Vázquez AM; Alfonso M; Mesa C; Rengifo E; Pérez R; Fernández LE
    Hybridoma; 2000 Jun; 19(3):241-7. PubMed ID: 10952412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering the binding site of an antibody against N-glycolyl GM3: from functional mapping to novel anti-ganglioside specificities.
    Rojas G; Pupo A; Gómez S; Krengel U; Moreno E
    ACS Chem Biol; 2013 Feb; 8(2):376-86. PubMed ID: 23138862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.
    Scursoni AM; Galluzzo L; Camarero S; Lopez J; Lubieniecki F; Sampor C; Segatori VI; Gabri MR; Alonso DF; Chantada G; de Dávila MT
    Clin Dev Immunol; 2011; 2011():245181. PubMed ID: 21941577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates.
    Fernández-Marrero Y; Roque-Navarro L; Hernández T; Dorvignit D; Molina-Pérez M; González A; Sosa K; López-Requena A; Pérez R; de Acosta CM
    Immunobiology; 2011 Dec; 216(12):1239-47. PubMed ID: 21802167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody.
    Piperno GM; López-Requena A; Predonzani A; Dorvignit D; Labrada M; Zentilin L; Burrone OR; Cesco-Gaspere M
    Gene Ther; 2015 Dec; 22(12):960-7. PubMed ID: 26181624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity.
    Roque-Navarro L; Chakrabandhu K; de León J; Rodríguez S; Toledo C; Carr A; de Acosta CM; Hueber AO; Pérez R
    Mol Cancer Ther; 2008 Jul; 7(7):2033-41. PubMed ID: 18645013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of an anti-idiotype monoclonal antibody related to GM3(NeuGc) ganglioside.
    Rodríguez M; Llanes L; Pérez A; Pérez R; Vázquez AM
    Hybrid Hybridomics; 2003 Oct; 22(5):307-14. PubMed ID: 14678648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.